Abstract
This Frost & Sullivan research service titled European Head and Neck Cancer
Therapeutics Markets provides market drivers, restraints and revenue forecasts
for this market. In this research, Frost & Sullivan' s expert analysts
thoroughly examine the chemotherapy and targeted therapies markets.
Table of Contents
1. EXECUTIVE SUMMARY
Overview
- Overview of the Head and Neck Cancer Therapeutics Market
2. GLOSSARY OF TERMS
List of Terms
3. MARKET OVERVIEW
Introduction
- Disease Characteristics
- Epidemiology
Market Definition and Segmentation
4. RESEARCH METHODOLOGY
Research Objectives and Scope
- Methodology
- Assumptions and Limitations
5. INDUSTRY CHALLENGES
Industry Challenges for the European Head and Neck Cancer Therapeutics Markets
- Challenges Faced by Pharmaceutical Companies
6. TOTAL EUROPEAN HEAD AND NECK CANCER THERAPEUTICS MARKET
Overview and Definitions
- Introduction
- Market Drivers
- Market Restraints
- Current Therapeutic Options
- Future Therapeutic Approaches
- Current Treatment Guidelines
- Pricing Trends
- Market Engineering Measurement Analysis
Competitive Analysis
- Profiles of Key Industry Participants and Market Share Analysis
- Pipeline Analysis
7. TOTAL FORECASTS FOR THE EUROPEAN HEAD AND NECK CANCER THERAPEUTICS MARKET
Forecasts
- Patient Forecasts
- Market Revenue Forecasts
- Geographical Trends
- Forecasts of Recent Entrants - Erbitux
8. PRICING AND REIMBURSEMENTS
Pricing and Reimbursement Issues
- Pricing and Reimbursement
9. STRATEGIC RECOMMENDATIONS FOR THE EUROPEAN HEAD AND NECK CANCER THERAPEUTICS MARKET
Market Engineering Recommendations
- Strategic Recommendations
10. DATABASE OF KEY INDUSTRY PARTICIPANTS
Key Industry Participants
- Key Participants in the Head and Neck Cancer Therapeutics Market
11. DECISION SUPPORT DATABASES
Habitual Indicators
- Prevalence of Smokers
- Prevalence of Male Smokers
- Prevalence of Female Smokers
- Alcohol Consumption
Healthcare Expenditure
- Expenditure
- Pharmaceutical R&D Expenditure
Demography
- Female Population Aged 65 Years and Above
- Male Population Aged 65 Years and Above
- Population Aged 65 Years and Above
- Percent of Population Aged 65 Years and Above
| 
